Evidence map›Paper›PMID 38740581›Full record

ArticleAbdominal radiology (New York)2024

Head-to-head comparison of three different US-based quantitative parameters for hepatic steatosis assessment: a prospective study.

Yan Zhou, Mengjin Nie, Hongyu Zhou, Feng Mao, Lin Zhao, Jianmin Ding, Xiang Jing

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Abdominal radiology (New York), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yan Zhou *Department of Ultrasound, Tianjin Third Central Hospital, Hedong District, No. 83 Jintang Road, Tianjin, 300170, China.
Mengjin Nie *Department of Ultrasound, Tianjin Third Central Hospital, Hedong District, No. 83 Jintang Road, Tianjin, 300170, China.
Hongyu ZhouDepartment of Ultrasound, Tianjin Third Central Hospital, Hedong District, No. 83 Jintang Road, Tianjin, 300170, China.
Feng MaoDepartment of Ultrasound, Zhongshan Hospital Fudan University, Shanghai, 200032, China.
Lin ZhaoDepartment of Ultrasound, Tianjin Third Central Hospital, Hedong District, No. 83 Jintang Road, Tianjin, 300170, China.
Jianmin DingDepartment of Ultrasound, Tianjin Third Central Hospital, Hedong District, No. 83 Jintang Road, Tianjin, 300170, China.
Xiang JingDepartment of Ultrasound, Tianjin Third Central Hospital, Hedong District, No. 83 Jintang Road, Tianjin, 300170, China. dr.jingxiang@vip.163.com.

Funding

Clinical Research Plan of Shanghai Hospital Development Center SHDC2020CR1031BNational Natural Science Foundation of China 82371986Tianjin Key Medical Discipline (Specialty) Construction Project TJYXZDXK-074CTianjin Municipal Health Commission KJ20170Tianjin Municipal Health Commission NQ20033Tianjin Municipal Health Commission ZD20014Tianjin Municipal Transportation Commission Science and Technology Development Plan Project 22JCQNJC01250
6 · The paper itself

Abstract

purposeTo evaluate the diagnostic performance of attenuation coefficient (AC), hepato-renal index (HRI) and controlled attenuation parameter (CAP) in quantitative assessment of hepatic steatosis by employing histopathology as reference standard.

methodsParticipants with suspected metabolic-associated fatty liver disease (MAFLD) who underwent US-based parameter examinations and liver biopsy were prospectively recruited. The distributions of US parameters across different grades of steatosis were calculated, and diagnostic performance was determined based on the areas under the receiver operating characteristic curve (AUC).

resultsA total of 73 participants were included, with hepatic steatosis grades S0, S1, S2, and S3 distributed as follows: 13, 20, 27, and 13 respectively. The correlation coefficients for CAP, AC, and HRI ranged from 0.67 to 0.74. AC and HRI showed a strong correlation with steatosis grade. The AUC for CAP and AC in diagnosing steatosis ≥ S1 were significantly higher at 0.99 and 0.98 compared to HRI's value. For diagnosing steatosis ≥ S2, the AUC of CAP (AUC: 0.85) was lower than that of AC (AUC: 0.94), and HRI (AUC: 0.94). Similarly for diagnosing steatosis S3, the AUC of CAP (AUC: 0.68) was lower than that of AC (AUC: 0.88), and HRI (AUC: 0.88).

conclusionThe AC and HRI values increased with the progression of hepatic steatosis grade, while CAP increased from S0 to S2 but not from S2 to S3. For mild steatosis diagnosis, CAP and AC showed superior diagnostic performance compared to HRI, while AC and HRI were more advantageous in differentiating moderate and severe steatosis.

Indexed as

Fatty LiverUltrasonographyAdultAgedBiopsyFemaleHumansLiverMaleMiddle AgedProspective StudiesAttenuation imagingControlled attenuation parameterHepatic steatosisHepato-renal indexMetabolic dysfunction-associated fatty liver disease

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.